Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Title:

Abbravation: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers-Plenum Publishers

Search In Publisher:

DOI

10.1016/0026-2714(92)90250-o

Search In DOI:

ISSN

0090-466X

Search In ISSN:
Search In Title Of Papers:

Pharmacokinetics and bioavailability of intravenou

Authors: R Jochemsen J J H Hogendoorn J Dingemanse J Hermans J K Boeijinga D D Breimer
Publish Date: 1982/06/01
Volume: 10, Issue: 3, Pages: 231-245
PDF Link

Abstract

The pharmacokinetics and bioavailability of nitrazepam following intravenous oral tablet and rectal solution administration were studied in seven healthy young male volunteers Nitrazepam plasma concentrations were determined by electroncapture GLC pharmacokinetic evaluations were made by compartmental analysis NONLIN and compared with the results obtained by a less stringent modelling of the data The plasma concentrationtime profile was similar for all three routes of administration Mean kinetic parameters as obtained by compartmental analysis of iv nitrazepam were distribution halflife 17 min volume of distribution after equilibrium 214 liters/kg total plasma clearance 616 ml/min elimination halflife 290 h The mean protein unbound fraction of nitrazepam in plasma was 123 and the clearance of the unbound fraction was 506 ml/min Absorption of oral nitrazepam started after the elapse of a lag time mean value 12 min and occurred as an apparent firstorder process in all but one subject with a mean absorption halflife of 16 min Distribution and elimination halflives were comparable with those following iv administration Following rectal administration of the nitrazepam solution rapid firstorder absorption occurred with a mean lag time of 4 min and a mean absorption halflife of 9 min Peak times median 18 min were significantly shorter than following oral administration median 38 min but there was little difference in peak concentrations The distribution halflife was similar to iv and oral administration but the elimination halflives were longer with a mean value of 331 h Following iv administration a good agreement was found between the results obtained by compartmental analysis using NONLIN and those obtained by a less stringent modelling of the data Following oral and rectal administration a good agreement between the two procedures was found for the elimination halflife estimation of bioavailability however was higher by compartmental analysis The mean bioavailability data showed that absorption is complete when nitrazepam is given orally and almost 20 lower when it is given rectally but considerable interindividual differences were observed


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and a “well-stirred” model
  2. Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies
  3. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma
  4. A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients
  5. Linear pharmacokinetic models: Geometric construction to determine transfer and elimination rate constants
  6. Modeling of drug response in individual subjects
  7. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model
  8. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man
  9. Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: Effect of model misspecification
  10. Estimation of drug binding parameters
  11. Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing
  12. Pharmacokinetics of teicoplanin in man after intravenous administration
  13. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics
  14. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  15. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  16. Simulation for population analysis of Michaelis-Menten elimination kinetics
  17. Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates

Search Result: